Although semaglutide and tirzepatide are GLP-1 agonists, tirzepatide generally works better for weight loss and obesity
Broussards Credentials and Philosophy As a board-certified family physician and aesthetic expert in Family Medicine with specialized training in Obesity Medicine, Ive spent two decades helping women who feel invisible in their own bodies
DSIP is generally considered safe when used properly, but some potential side effects or risks include: Mild headaches or dizziness
Therefore, more research is needed to fully understand ILCs therapeutic potential and mechanisms
Their short half-lives mean timing matters: administration is conventionally described around bedtime or after fasting, aiming to align the induced pulse with the body's own nocturnal GH release and to avoid the GH-blunting effect of elevated insulin after meals
Our Approach For patients with injuries that have plateaued despite conventional treatment, peptide therapy is a reasonable topic to explore with realistic expectations and proper medical oversight